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Abstract
Background: The impact of telemedicine application on the management of diabetes patients is unclear, as the
results are not consistent among different studies. The objective of this study is to conduct a systematic review and
meta-analysis of randomized controlled trials (RCTs) assessing the impact of telemedicine interventions on change in
hemoglobin A1c (HbA1c), blood pressure, LDL cholesterol (LDL-c) and body mass index (BMI) in diabetes patients.
Methods: Electronic databases MEDLINE, Cochrane Central Register of Controlled Trials and LILACS were
searched to identify relevant studies published until April 2012, supplemented by references from the selected
articles. Study search and selection were performed by independent reviewers. Of the 6.258 articles retrieved, 13
RCTs (4207 patients) were included. Random effects model was applied to estimate the pooled results.
Results: Telemedicine was associated with a statistically significant and clinically relevant absolute decline in HbA1c
level compared to control (mean difference -0.44% [-4.8 mmol/mol] and 95% confidence interval [CI] -0.61 to -0.26%
[-6.7 to -2.8 mmol/mol]; p<0.001). LDL-c was reduced in 6.6 mg/dL (95% CI -8.3 to -4.9; p<0.001), but the clinical
relevance of this effect can be questioned. No effects of telemedicine strategies were seen on systolic (-1.6 mmHg
and 95% CI -7.2 to 4.1) and diastolic blood pressure (-1.1 mmHg and 95% CI -3.0 to 0.8). The 2 studies that
assessed the effect on BMI demonstrated a tendency of BMI reduction in favor of telemedicine.
Conclusions: Telemedicine strategies combined to the usual care were associated with improved glycemic control
in diabetic patients. No clinical relevant impact was observed on LDL-c and blood pressure, and there was a
tendency of BMI reduction in diabetes patients who used telemedicine, but these outcomes should be further
explored in future trials.
Citation: Marcolino MS, Maia JX, Alkmim MBM, Boersma E, Ribeiro AL (2013) Telemedicine Application in the Care of Diabetes Patients: Systematic
Review and Meta-Analysis. PLoS ONE 8(11): e79246. doi:10.1371/journal.pone.0079246
Editor: Sompop Bencharit, University of North Carolina at Chapel Hill, United States of America
Received May 26, 2013; Accepted September 20, 2013; Published November 8, 2013
Copyright: © 2013 Marcolino et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by Brazilian research agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (563893/2010-9), Pró-
Reitoria de Pesquisa da Universidade Federal de Minas Gerais and Fundação de Amparo a Pesquisa do Estado de Minas Gerais (PPM 328-08). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: milenamarc@gmail.com
Introduction
Diabetes mellitus (DM) has taken epidemic proportions
throughout the world and is considered among the most
challenging health problems in the 21st century [1]. The
disease is associated with a number of health-related
complications, high morbidity and mortality rates and thus
imposes substantial social and economic burdens worldwide
[2].
Challenges in the care of diabetic patients require innovative
management strategies to improve glycemic and pressoric
control, as these are frequently above the desired goals [3].
The optimal management requires an organized, systematic
and coordinated approach [2]. Strong evidence demonstrates
beneficial effects of patient monitoring and education, focused
on a prominent role of the individual self-care with the support
of healthcare professionals [4]. This brings into focus the great
advances in telecommunication technology and information
technology, which can be exploited to improve diabetes
management [5,6]. Telemedicine can be a strategy for closer
monitoring and intervention to achieve not only better metabolic
control, but also to help in the global care of individuals with
multiple chronic illnesses [3,7,8].
Over the last decade, several studies have addressed the
feasibility and efficacy of telemedicine strategies on the
management of diabetes patients [9]. Many studies have
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proved it to be feasible, but the real impact of this of
intervention in general and specific clinical situations is still
unknown and poorly documented, as the results are not
consistent among different studies [6,10]. If proven beneficial,
the intervention could be widely disseminated to clinical
practice and might help to reduce the burden of the disease.
The objective of this study is to conduct a systematic review
and meta-analysis of randomized controlled trials (RCTs)
assessing the impact of telemedicine interventions combined
with usual care compared to usual care alone on the
management of adult patients with DM type 1 or 2, in terms of
change in hemoglobin A1c, blood pressure, LDL cholesterol
(LDL-c) levels or body mass index (BMI).
Methods
This systematic review and meta-analysis was conducted in
accordance with the Preferred Reporting Items for Systematic
Review and Meta-Analyses (PRISMA) statement [11]. The
investigators wrote a protocol and registered it with the
International Prospective Register of Systematic Reviews
(identification number: CRD42012002779) in August 2012 [12].
Data sources and searches
A literature search with no language restriction was
performed using MEDLINE (accessed by Pubmed), Cochrane
Central Register of Controlled Trials and LILACS databases to
identify relevant studies published until April 2012. On Pubmed,
combinations of the MESH terms diabetes, medical informatics,
clinical decision support system, computer assisted decision
making, information systems and telemedicine were used. In
other databases, different combinations of the same terms and
the keywords mobile health, telehealth, telehealthcare, health
information technology were used. The search was
supplemented by the reference lists of the identified papers.
Study selection
This study included RCTs that compared any strategy of
telemedicine application in adult care (i.e. patients ≥18 years)
with DM type 1 or 2 in which there was a direct or indirect (i.e.
via another healthcare provider) personalized feedback from a
healthcare practitioner to the patient about the forwarded
clinical data, with a control group not using telemedicine. We
restricted ourselves to trials that studied outpatients, and that
evaluated at least one of the following outcomes: HbA1c, blood
pressure, BMI or LDL-c.
The strategies of telemedicine application included in this
review were computerized systems for information exchange,
video conferencing, and exchange of information via telephone
or other mobile devices, short message service, or through the
internet.
Exclusion criteria were as follows: (1) gestational diabetes;
(2) studies in patients under 18 years; (3) RCT which did not
include feedback from a healthcare practitioner to the patient or
other healthcare provider about forwarded clinical data; (4)
studies with less than 6 months of follow-up; (5) duplicate
publications or substudies of included trials. In this case, the
publication with longer follow-up was chosen.
Data extraction and quality assessment
Titles and abstracts of retrieved articles were independently
evaluated by 2 investigators (J.X.M. and M.S.M.). Abstracts
that did not provide enough information for analysis of the
intervention or the methodology regarding the inclusion and
exclusion criteria defined in this review were retrieved for full-
text evaluation.
Subsequently, the 2 investigators independently evaluated
full-text articles and determined study eligibility. Disagreements
were solved by consensus, and if disagreements persisted, by
a third investigator (A.L.R.). The corresponding authors were
contacted as needed to obtain data not included in the
published report.
The two investigators independently conducted data
extraction, and disagreements were solved by the third
investigator. Study quality assessment included adequate
sequence generation, allocation concealment, blinding of
outcomes assessors, use of intention-to-treat analysis, and
description of losses and exclusions [13]. Studies without clear
descriptions of an adequate sequence generation, and studies
with loss to follow-up greater than 20% if analyzed by intention
to treat (ITT) and greater than 5% if not ITT were excluded.
Data synthesis and analyses
The primary outcome was absolute changes in HbA1c from
baseline to follow-up. HbA1c is recognized as a valuable
indicator of treatment effectiveness in patients with diabetes
[2], because it reflects average glycemia over several months
and is strongly correlated with diabetes complications [2,14,15].
Secondary outcomes included the absolute changes of LDL-
c, systolic blood pressure (SBP), diastolic blood pressure
(DBP) and BMI from baseline to follow-up. They were obtained
from original studies or calculated (differences in arithmetic
means before and after the intervention) [16]. When deviation
of the mean difference was not available, the authors were
contacted. In case of no response or no availability of the
requested information, variance was estimated by using the
reported confidence intervals, reported p-values, or an
imputation using the standard deviation at follow-up in both
groups to calculate the standard error of difference. One study
reported data on two intervention groups and one control group
[3]. In meta-analysis, data of these intervention groups were
combined and compared to the control group.
A random-effects model was used for pooling the included
studies, as clinical heterogeneity was expected. Statistical
heterogeneity of the treatment effect among studies was
assessed using Cochran Q test, and the inconsistency I2 test in
which values greater than 50% were considered indicative of
high heterogeneity. Between-study heterogeneity was
performed using the chi-square statistic. A p-value <0.05 was
considered statistically significant.
Sensitivity and subgroup analyses were pre-specified and
performed only for the primary outcome. In sensitivity analyses,
the effect size was examined by omitting studies individually
and also excluding simultaneously studies with extreme results
and those with the biggest losses. In this case, the effect sizes
were compared by using z tests.
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Subgroup analyses aimed to assess whether there was a
difference in results of HbA1c in studies which included
exclusively patients with DM type 1 vs. type 2, interventions
which included changes in patient prescription through
telemedicine vs. the ones which did not, intervention made by
physicians vs. by nurses, interventions that lasted for 6 months
vs. the ones that lasted at least one year. Although not pre-
specified in the protocol, a subgroup analysis regarding the
average HbA1c on baseline was performed.
A funnel plot of the trial effect size by its standard error was
constructed to assess the possibility of publication bias [17].
The symmetry of the plot was evaluated both visually and
formally with Egger’s test. The implications for our results were
assessed by the fail-safe N and the trim-and-fill method [18].
Statistical analysis was performed using Comprehensive
Meta-Analysis version 2.0.
Results of the Review
Description of the studies
A flow diagram of search and selection is shown in Figure 1.
The database search resulted in 6258 (6039 Pubmed, 117
Lilacs, 102 Cochrane Trials) articles and 29 other articles were
identified from the references of included studies, totalizing
6287 articles. Of these, 6203 (5984 Pubmed, 117 Lilacs, 102
Cochrane Trials) were excluded after title and/or abstract
analysis. Therefore, 84 full text articles were assessed for
eligibility. Of these, 69 articles were excluded. Consequently,
15 articles with 13 studies were included in the systematic
review.
The main characteristics of the included studies are
summarized in Tables 1 and 2. All 13 studies selected for the
review were published in English. Included studies had a total
of 4207 patients, 56% were men, 2252 patients were
randomized to telemedicine strategies and 1955 to usual care.
Ten studies took place in United States and 3 in Europe. One
study [19] received funding from industry alone, nine studies
[3,10,20-25] were funded by the government alone and three
studies [4,26,27] received funding from both.
Interventions took place in different care settings: 8 studies
took place in primary care, 4 studies secondary care and 1
included both primary and secondary care settings. The
duration of the intervention was 6 months in 6 studies, 12
months in 6 and 18 months in one study.
The intervention was particularly targeted at monitoring
clinical values, or monitoring combined with education. As per
design of our meta-analysis, all studies included personalized
feedback from a healthcare practitioner to the patient or other
healthcare provider about the forwarded clinical data. The
intervention had varying degrees of complexity. Telemedicine
strategies included different combinations of transmission of
monitoring data, videoconferencing, educational web site,
educational reminders, email exchange, evidence-based
message to the general physician, teleconsultation, telephone
calls, short message service and forum discussion.
Eight trials reported the frequency of data transmission from
patients to nurses (six trials) or physicians (two trials). Eight
trials provided information about the frequency of feedback of
information to patients. The majority of the trials succeeded in
data transmission at a maximum frequency of once a week.
Quality (Risk of Bias) Assessment
Among the included studies, 100% presented adequate
sequence generation, 62% reported allocation concealment (8
of 13), 38% had blinded assessment of outcomes (5 of 13),
92% described losses to follow-up and exclusions (12 of 13),
and 92% used the intention-to-treat principle for statistical
analyses (12 of 13) (Table 3).
Association of intervention on the primary and
secondary outcomes
Telemedicine strategies were associated with a significant
absolute HbA1c reduction of -0.44% (-4.8 mmol/mol) (95%
confidence interval [CI] -0.61 to -0.26% [-6.7 to -2.8 mmol/mol];
p<0.001) when compared to the usual care (Figure 2). There
was evidence of heterogeneity (I2 73%; p for heterogeneity
<0.001; range of effects -1.10 to -0.10%).
Five studies (2889 patients) assessed the effect of
telemedicine strategies on LDL-c. There was a significant
reduction of 6.6 mg/dL (95% CI -8.3 to -4.9 mg/dL; p<0.001).
There was no evidence of a significant heterogeneity (I2 24%; p
value for heterogeneity 0.259) (Figure 3A).
Eight studies (3291 patients) assessed the effect on SBP,
and 7 (2989 patients) assessed the effect on DBP. There was
no significant effect of telemedicine strategies on SBP (effect
size -1.6 mmHg; 95% CI -7.2 to 4.1 mmHg; p=0.585) and DBP
(effect size -1.1 mmHg; 95% CI -3.0 to 0.8 mmHg; p=0.258)
when compared to the usual care (Figures 3B and 3C). There
was evidence of heterogeneity for both (SBP I2 94%, p for
heterogeneity <0.001, range -7.67 to 7.50 mmHg; DBP I2 84%,
p for heterogeneity <0.001, range -6.0 to 1.5 mmHg ).
Only 2 studies (397 patients) assessed the effect on BMI,
therefore it was not possible to perform a meta-analysis. Both
studies demonstrated a non-significant reduction on BMI.
Secondary analyses
In sensitivity analyses, studies were individually omitted from
the meta-analysis, and the effect size remained fairly the same
(Table 4). Even when studies with extreme results and those
with the biggest losses [10,22,26] were simultaneously omitted,
there was no significant difference in HbA1c reduction (-0.44%
vs. -0.56%, p=0.70).
Subgroup analysis compared studies which included
exclusively patients with diabetes type 1 (2 studies, 145
patients) vs. patients with diabetes type 2 (6 studies, 1180
patients) and demonstrated a higher HbA1c reduction in the
first group: -0.86% (-9.4 mmol/mol) (95% CI -1.12 to -0.59%
[-12.2 to -6.4 mmol/mol]) vs. -0.44% (-4.8mmol/mol) (95% CI
-0.74 to -0.15% [-8.1 to -1.6 mmol/mol]), p=0.039.
It was impossible to stratify patients regarding baseline
HbA1c because patient-level analyses were not performed.
Studies with an average baseline HbA1c equal to or higher
than 8.0% [64.0 mmol/mol] were compared to the ones with an
average lower than 8.0% and demonstrated a higher impact of
telemedicine in the first group: -0.64% (7.0mmol/mol) (95% CI
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-0.93 to -0.35% [-10.2 to -3.8 mmol/mol]) vs. -0.26% (-2.8
mmol/mol) (-0.43 to -0.10% [-4.7 to -1.1 mmol/mol]), p=0.027.
Interventions which included changes in patient prescription
through telemedicine (4 studies, 334 patients) were associated
with a more pronounced HbA1c reduction than the ones which
did not (7 studies, 3435 patients): -0.75% (-8.2 mmol/mol)
(95% CI -1.05 to -0.43% [-11.5 to -4.7 mmo/mol]) vs. -0.30%
(-3.3 mmol/mol) (95% CI -0.45 to -0.14% [-4.9 to -1.5 mmol/
mol]), p=0.013.
Studies in which the intervention was made by physicians (3
studies, 847 patients) were compared to the ones in which it
was made by nurses (9 studies, 3039 patients), and revealed
no difference in HbA1c change: -0.53% (-5.8 mmol/mol) (95%
CI -0.94 to -0.13% [-10.3 to -1.4 mmol/mol]) vs. -0.43% (-4.7
mmol/mol) (95% CI -0.64 to -0.22% [-7.0 to -2.4 mmol/mol]),
p=0.654.
There was a tendency of a higher HbA1c reduction in
interventions which lasted 6 months (6 studies, 741 patients)
when compared to the ones that lasted at least one year (7
studies, 3466 patients; in only one study the follow-up was
longer than one year): -0.57% (-6.2 mmol/mol) (95% CI -0.85 to
-0.30% [-9.3 to -3.3 mmol/mol]) vs. -0.30% (-3.3 mmol/mol)
(-0.48 to -0.11% [-5.2 to -1.2 mmol/mol]), p=0.099.
Publication Bias Assessment
The subject impression of the funnel plot test suggested an
asymmetry (Figure 2). Toward the bottom of the graph there
are more studies on the left (indication a higher impact), which
is consistent with the possibility that some studies are missing
Figure 1.  Flow of information through the different phases of the systematic review.  
doi: 10.1371/journal.pone.0079246.g001
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Table 1. Main characteristics of included studies.
Study Scenario
Mean age
in years
(SD)
Male
sex
(%)
Duration of
diabetes I
years (SD)
Duration of
diabetes C
years (SD)
Mean
basal
HbA1C
(%)
Type of
diabetes Treatment in use
Losses
(%)
Duration
of follow
up
(months) Outcomes
Bond et al,
2007
University of
Washington Diabetes
Center, Puget Sound
Health System, and
local diabetes fairs in
the greater Seattle
area, United States
67.2
(11.9) 55.0 16.1 (10.5) 17.8 (11.7) 7.1
1 and 2
(87%
DM2)
49% insulin, 45% insulin
and oral agents and 6%
diet and exercise
0 6
HbA1c, BP,
weight, total
and HDL
cholesterol
Bujnowska et
al, 2011
Primary care units in
Poland
55.3
(52.6) 53.5 8.1 (7.6) 7.7 (6.8) 7.6 2
Groups equally divided in
insulin users and non-
users
5.0 6 HbA1C, BMI,BP
Charpentier et
al, 2011
Outpatient clinics of
17 hospital sites in
France
33.8
(12.9) 36.7 14.7 (9.1) 16.9 (10.5) 9.1 1
Basal-bolus insulin by
multiple injections or
pump for at least 6
months
10.0 6 HbA1C
Kirkman et al,
1994 &
Weinberger et
al, 1995
General Medicine
Clinic of the Durham
Department of
Veterans Affairs
Medical Center,
North Carolina,
United States
63.5
(19.7) 99.2 11.5 (8.4) 10.3 (7.7) 10.7 2
Currently use of oral
hypoglycemic agent or
insulin and care at VA
general medicine clinic
were inclusion criteria
8.7 12 HbA1C
Montori et al,
2004
Diabetes clinics
Primary care units
affiliated with Mayo
Clinic, United States
42.9 (4.7) 32.5 19.0 (1.8) 17.9 (2.1) 9.0 1
Multiple daily insulin
injections or insulin
pumps
19.0 6 HbA1C
Piette et al,
2000
2 general medicine
clinics of Santa Clara
Valley Medical
Center in California,
United States
55.0
(10.0) 58.5
Not
informed
Not
informed 8.7
Not
informed
Use of a hypoglycemic
agent (oral or insulin)
was inclusion criteria.
37.5% used insulin
11.0 12 HbA1C
Piette et al,
2001
Veterans Affairs
outpatients clinics (3
general medicine
clinics and 1 diabetes
clinic) in California,
United States
60.5
(20.0) 97.0
Not
informed
Not
informed 8.2
Not
informed
Active use of a
hypoglycemic agent was
inclusion criteria. 47%
used insulin
6.8 12 HbA1C
Ralston et al,
2009
UW Internal Medicine
Clinic of Washington
University, United
States
57.0* 50.6 Notinformed
Not
informed 8.0 2
Diet, oral medications
and or insulin (38% used
insulin)
11.0 12
HbA1C, BP,
total
cholesterol
Ralston et al,
2009
UW Internal Medicine
Clinic of Washington
University, United
States
57.0* 50.6 Notinformed
Not
informed 8.0 2
Diet, oral medications
and or insulin (38% used
insulin)
11.0 12
HbA1C, BP,
total
cholesterol
Rodriguez-
Idígoras et al,
2009
Primary care units in
Malaga, Spain
64.0
(21.5) 51.5 11.3 (0.6) 10.2 (0.6) 7.5 2
Diet, oral medications
and or insulin 9.5 12
HbA1C, BP,
BMI, lipids
Shea et al, 2006
& Shea et al,
2010
Primary care units in
New York State,
United States
71.0
(13.3) 37.0
Not
informed
Not
informed 7.4 1 and 2
Diet, oral medications
and or insulin 14.9 12
HbA1C, BP,
lipids
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from the right. This visual impression was confirmed by Egger’s
test, yielding a significant p-value (0.022). However, the fail-
safe N for our pooled analysis is 273000, which is reassuring
since it is very unlikely that there are over 1000 unpublished or
undiscovered studies for every 1 study we found. Additionally,
the trim-and-fill method revealed that publication bias did not
interfere with the interpretation of results The method
suggested that one study is missing, and the imputed effect
size was -0.41% (95% CI -0.58 to -0.23%), which is similar to
the original effect, suggesting that the apparent publication bias
is insufficient to affect our results or interpretations in a
meaningful way (Figure 4).
Discussion
This systematic review (13 studies, 4207 patients) indicates
that in diabetes patients, telemedicine strategies concomitant
to the usual care are associated with a mean HbA1c decline of
−0.44% (-4.8 mmol/mol) when compared to the usual care
alone. HbA1c is recognized as a valuable indicator of treatment
effectiveness in patients with diabetes [2], because it reflects
average glycemia over several months and is strongly
correlated with diabetes complications [2,14,15]. Additionally,
our analyses demonstrate that there was no clinical relevant
impact on LDL-c (an effect size of only 6.6 mg/dL) and no
impact on blood pressure. It was impossible to perform a meta-
analysis to assess the impact on BMI, but there is a tendency
of its reduction with the use of telemedicine.
The lack of a clinical significant impact on LDL-c and the
absence of impact on blood pressure should not be interpreted
as a definite finding. Regarding hypertension, a recent RCT
which included a large sample of hypertensive patients (7.3%
of them had diabetes) who were willing to monitor their blood
pressure and self-titrate medication has shown that self-
management of hypertension in combination with
telemonitoring of blood pressure measurements resulted in
significant reduction in blood pressure in 6 and 12-month
follow-up when compared to usual care [27]. No study in the
present meta-analysis included an intervention similar to that
one. Therefore, the telemedicine strategy design might have
not been appropriate to generate a significant impact on
hypertension and LDL-c, and the intervention might be more
effective in a motivated sample of patients, as was the case.
This should be in mind when designing new studies to address
these outcomes.
Our findings also demonstrated that the impact of
telemedicine strategies in reducing HbA1c was more
pronounced in diabetes type 1. Type 1 diabetes patients are
unique in that they have absolute insulin deficiency and
consequently the have more pronounced glycemic variability
than type 2 diabetes patients [2,28]. Their management always
involves insulin administration, whereas type 2 diabetes
patients may be managed using lifestyle changes and oral
hypoglycemic agents. These differences could influence the
impact of individual’s self-management strategies and affect
outcome measures [29]. Additionally, type 2 diabetes is more
common in older adults. Compared with younger adults, older
adults report greater anxiety about using computers, lower use
of technology and less confidence in their technological abilities
[6] Therefore, some patients may have found difficulties in
dealing with the telemedicine applications, for example, to
upload blood glucose results to the website or to access online
educational materials.
Interventions which included changes in patient prescription
through telemedicine were associated with a greater benefit on
HbA1c reduction than the ones which did not, and there was no
Table 1 (continued).
Study Scenario
Mean age
in years
(SD)
Male
sex
(%)
Duration of
diabetes I
years (SD)
Duration of
diabetes C
years (SD)
Mean
basal
HbA1C
(%)
Type of
diabetes Treatment in use
Losses
(%)
Duration
of follow
up
(months) Outcomes
Smith et al,
2008
Primary care units
affiliated with Mayo
Clinic's site in
Rochester, United
States
61.0 (8.2) 47.5 12.9 (3.3) 14.0 (3.4) 7.3
1 and 2
(93%
DM2)
Diet, oral medications
(46%) and or insulin
(33%)
4.0 21
HbA1C, LDL,
systolic and
diastolic BP
Stone et al,
2010
Veterans Affairs
Primary care clinics
in Pittsburgh, United
States
Not
informed 98.6
Not
informed
Not
informed 9.5 2
Pharmacological
treatment for at least 1
year: 76% used oral
medications, 58% used
insulin
8.6 6 HbA1C, BP,lipids, weight
Wakefiel et al,
2011
Veterans Affairs
Primary Care Clinics
in Iowa City, United
States
68.0
(10.0) 98.0
Not
informed
Not
informed 7.2 2 Not specified 19.0 6 HbA1C, SBP
*. Standard deviation was not informed
Abbreviations: BP: blood pressure; DM2: diabetes mellitus type 2; HbA1c: hemoglobin A1c; SD: standard deviation
doi: 10.1371/journal.pone.0079246.t001
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Table 2. Characteristics of included studies regarding the telemedicine intervention.
Study Intervention
Medium used for
interaction
Target of
intervention
Applicator of
intervention
Applicator
changed
medication
Planned frequency of
intervention
Real frequency of
intervention (average)
Bond et al,
2007
Internet program including
communication with nurse (SMS,
chat, email) and register of self-
management activities (glucose,
BP) by patients. Nurse
monitored data and contacted
patients when necessary. Forum
discussion with the principal
investigator.
Web Patients Nurse No
Not informed, except
for the forum
discussions: weekly
Not informed
Bujnowska et
al, 2011
Telehome monitoring system.
Patients sent glucose data, and
the system analyzed and
organized data according to
protocols that included alerts and
SMS in case of critical values for
urgent medical attention.
Telemonitoring
device and mobile
phone
Patients Physicians Yes
Patients should
transmit glucose
values at least once a
week. Practitioners
sent feedback in case
of critical values
Data transmissions:1.64/
patient/week (total 1.850).
Interventions (email,
phone calls, SMS): 0.42/
patient/week (total 474).
Charpentier
et al, 2011
Diabeo software use plus
teleconsultations (group 3).
Diabeo: software for patient's
smartphones with insulin bolus
calculators, plasma glucose
targets, automatic algorithms,
data transmission to medical
staff.
Mobile phone and
telephone calls Patients Physicians Yes
Teleconsultations
every 2 weeks
8.70 teleconsultations/
patient in 6 months. Mean
duration of each
teleconsultation 7.4
minutes
Kirkman et al,
1994 &
Weinberger et
al, 1995
Calls to educate patients,
facilitate adherence to treatment,
monitor health status, improve
problem solving capacity, and
facilitate access to care. Patients
could call nurses. Physicians
called patients if necessary,
according to nurses alerts.
Telephone calls Patients Nurse No
Monthly nurse calls
(more frequent if
necessary). Patients
could call whenever
they wanted
13 nurse contacts per
patient (1.10/patient/
month). 12 min/contact. In
19% of contacts nurses
alerted physicians of
problems
Montori et al,
2004
Transmission of glucose levels
and feedback from the study
nurse.
Telephone calls Patients Nurse* Yes
Every 2 weeks, 24h
after patients
transmitted glucometer
data
Nurses spent, per patient,
76 min reviewing data, 9
min discussing with
endocrinologist and 68
min returning to patients
Piette et al,
2000
ATDM: calls in which patients
reported clinical information
using the keypad and could
listen to health promotion
automated messages. Nurse
reviewed the reports and
contacted patients.
Telephone calls Patients Nurse No
Biweekly ADTM calls.
Nurse reviewed data
weekly and called
patients as necessary
1.40 ADTM calls/month.
Half of patients completed
78% or more of their
attempted assessments
Piette et al,
2000
ATDM: calls in which patients
reported clinical information
using the keypad and could
listen to health promotion
automated messages. Nurse
reviewed reports and contacted
patients.
Telephone calls Patients Nurse No
ADTM calls: not
informed. Nurse
reviewed data weekly
and called patients as
necessary
15 ADTM calls (1.25/
month) and 12 glucose
transmissions (1.00/
month). Nurse
communicated with
patients 1.10/month
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Table 2 (continued).
Study Intervention
Medium used for
interaction
Target of
intervention
Applicator of
intervention
Applicator
changed
medication
Planned frequency of
intervention
Real frequency of
intervention (average)
Ralston et al,
2009
Website including electronic
medical records, stored glucose
values, online diary with
feedback, educational website
on diabetes. Email exchange
with nurses
Web Patients Nurses Yes
Nurse analyzed
glucose data at least
once a week. Email
exchange weekly in
the beginning of fw.
Patients sent emails to
nurses whenever they
wanted
76% of patients accessed
their medical records,
69% sent emails to
nurses, 43% uploaded
glucose measures (total
189 uploads) and 33%
entered data about diet,
exercise, medication
Rodriguez-
Idígoras et al,
2009
Transmission of glucose values
to a call center, which had an
alarm and a protocol of
interventions in case of abnormal
values. Patients could call their
physician or the call center staff
and vice versa
Mobile phone Patients Nurses andphysicians
Not
informed Not informed
7.40 glucose
transmissions/patient/
month; patients made
3.00 and received 2.60
phone calls per month
Shea et al,
2006 & Shea
et al, 2010
Home telemedicine unit
connected to glucose and blood
pressure monitors,
videoconferencing, web portal
with access to patients clinical
data, educational web site
created for the project by ADA
Telemonitoring
device,
videoconferences
and Web
Patients Nurses No Not informed
28 videoconferences, 560
glucose uploads, 185 BP
uploads, 49 visits to
patients web portals, 3
visits to educational site
per patient
Smith et al,
2008
After a patient visit, an
endocrinologist reviewed the
records and created a note with
suggestions attached to an EB
message that was sent to the
PCP 48h before the next visit of
that patient
Web
Primary
care
physicians
Physicians
(endocrinologists) No Each patient visit
Endocrinologists reviewed
1361 consultations, 60%
resulted in suggestions.
PCP informed they used
49% of them
Stone et al,
2010
Telemonitoring device: daily
educational reminders, daily
transmission of data (glucose,
BP, weight). Nurse analyzed and
contacted patients when
necessary, and also called at
least monthly for individualized
counseling
Telemonitoring
device and
telephone calls
Patients Nurses Yes*
Daily transmission of
glucose and BP. Call
whenever necessary,
more frequent if high
risk detected by the
data. Monthly calls for
counseling
Duration of nurse-patient
telephone contact in
hours/patient/month:
intervention 1.3h, controls
0.3h. 11% of patients
never transmitted data.
Wakefiel et al,
2011
Home telehealth device. Patients
entered BP and glucose and
answered questions, receiving
automated feedback. Nurses
reviewed data daily and
contacted patients by telephone,
letter or individualized messages
on the device. Physicians
contacted if BP or glucose
values reached pre-determined
values
Telemonitoring
device and
telephone calls
Patients Nurses No
Daily transmissions of
data and automated
device messages.
Nurse and physicians
individualized contacts
as necessary
Not informed
*. Supervised by an endocrinologist
Abbreviations: ADA: American Diabetes Association; ATDM: Automated Telephone Disease Management; BMI: body mass index; EB: evidence-based; PCP: primary care
physician; SMS: short message service
doi: 10.1371/journal.pone.0079246.t002
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difference regarding intervention made by physicians or
nurses. These findings are important to address
recommendations on telemedicine design strategies in clinical
practice. The lack of difference between physicians and nurses
impacts significantly in decreasing the costs of the intervention
if applied to the healthcare system.
Another important finding was the tendency of a higher
HbA1c reduction in interventions which lasted 6 months when
compared to the ones that lasted at least one year. Although it
did not reach statistical significance, it suggests a trend of
decreasing intervention impact over time. This finding suggests
that in clinical practice contact through telemedicine and
positive motivation should be intensified over time, in order not
to decrease the impact on glycemic control. Additionally, a
more participatory design approach, involving target users in
Table 3. Risk of bias of included studies (n = 13).
Study
Adequate sequence
generation Allocation concealmentBlinding of outcome
Description of losses and
exclusions
Intention to treat
analysis
Bond et al, 2007 Yes Unclear Yes No* Yes
Bujnowska et al, 2011 Yes Unclear Unclear Yes No
Charpentier et al, 2011 Yes Unclear No Yes Yes
Kirkman et al, 1994 & Weinberger et al, 1995 Yes Unclear Yes Yes Yes
Montori et al, 2004 Yes Unclear Unclear Yes Yes
Piette et al, 2000 Yes Yes No Yes Yes
Piette et al,2001 Yes Yes Unclear Yes Yes
Ralston et al, 2009 Yes Yes Unclear Yes Yes
Rodriguez-Idígoras et al, 2009 Yes Yes No Yes Yes
Shea et al, 2006 & 2010 Yes Yes Yes Yes Yes
Smith et al, 2008 Yes Yes Yes Yes Yes
Stone et al, 2010 Yes Yes Yes Yes Yes
Wakefiel et al, 2011 Yes Yes Unclear Yes Yes
*. The authors were contacted and reported no losses.
doi: 10.1371/journal.pone.0079246.t003
Figure 2.  Absolute changes in HbA1c of individual studies of telemedicine associated to usual care vs. usual care.  
doi: 10.1371/journal.pone.0079246.g002
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Figure 3.  Absolute changes in LDL cholesterol (A), in systolic blood pressure (B) and diastolic blood pressure (C) of
individual studies of telemedicine associated to usual care vs. usual care.  
doi: 10.1371/journal.pone.0079246.g003
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developing personalized interventions, might enhance
persistence in usage and adherence to treatment [30].
This study was a rigorous systematic literature review that
focused exclusively on RCTs in which telemedicine strategies
included a personalized feedback from a healthcare
practitioner to the patient or to other healthcare provider.
Although only 5 studies had blinded assessment of outcomes,
Table 4. Sensitivity analyses on hemoglobin A1c (%) effect
size removing studies individually.
Study name Statistics with study removed
 Point Lower limit Upper limit
Bond et al, 2007 -0,43 -0,62 -0,24
Bujnowska et al, 2011 -0,46 -0,64 -0,27
Charpentier et al, 2011 -0,37 -0,53 -0,21
Montori et al, 2004 -0,42 -0,60 -0,24
Piette et al, 2001 -0,46 -0,66 -0,27
Piette et al, 2000 -0,45 -0,64 -0,26
Ralston et al, 2009 -0,40 -0,58 -0,23
Rodriguez-Idígoras et al, 2000 -0,47 -0,66 -0,28
Shea et al, 2006 -0,48 -0,65 -0,30
Smith et al, 2008 -0,44 -0,63 -0,24
Stone et al, 2010 -0,40 -0,58 -0,23
Wakefiel et al, 2011 -0,46 -0,65 -0,26
Weinberger et al, 1995 -0,43 -0,61 -0,25
Original effect size -0,44 -0,61 -0,26
doi: 10.1371/journal.pone.0079246.t004
the outcomes were objective measures, with a low risk of bias
in their assessment.
Previous systematic reviews with less methodological rigor
have not performed meta-analysis or failed to detect a
significant impact of different telemedicine strategies on
glycemic control [6,26,30-32]. Methodological limitations may
have biased the results, including inaccurate or incomplete
indexing in the database, or a weak search strategy, leading to
incomplete accounting of existing studies; limited or no
assessment of study quality; and inclusion of weak studies.
One systematic review demonstrated a significant decrease in
HbA1c, but with a lower impact (effect size -0.22% [-2.4 mmol/
mol]; 95% CI -0.35 to -0.08% [-3.8 to -0.9 mmol/mol]) [33]. The
inclusion of RCTs independent of study quality and the
possibility of selection bias on observational studies may have
influenced the results.
The evidence presented here could support the
implementation of telemedicine in the care of diabetes patients.
It has already been shown that telemedicine help improving
patient care and access to specialized care, in particular in
rural areas with limited accesses to health care facilities [34],
and it is expected to facilitate a productive interaction between
the patient and the health care provider in order to achieve
improved treatment results and lower treatment costs [35]. This
review did not address the cost-effectiveness of the
intervention. Another systematic review, specific on
teleconsultation, reported controversy about that, but cost-
effectiveness was not measured uniformly among the various
studies, and some of them were observational studies without
a control group [30]. This question is of utmost importance for
Figure 4.  Observed studies are shown as open circles, and the observed point estimate is shown as open diamond.  The
imputed study is shown as a filled circle, and the imputed point estimate is shown as a filled diamond.
doi: 10.1371/journal.pone.0079246.g004
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decision makers and therefore should be addressed in further
clinical trials.
In order to make these results applicable to clinical practice,
it is also important to take into account that telemedicine may
not be appropriate for all patients. There are some factors that
are described as important elements for the success, such as
awareness of the significance of the disease and its
consequences, willing to participate actively in the treatment
and in preventing complications and positive motivation [4].
Patient computer skills and adherence to the technology are
also important depending on the complexity of the telemedicine
strategy [36].
The main limitation of this meta-analysis is the heterogeneity.
To address this, we have performed analyses to identify clinical
and methodological differences between studies. Some factors
could not be addressed, as the type of telemedicine
intervention, because it was too diverse among studies. As the
analyses were not based on individual data, it was not possible
to stratify according to the basal HbA1c, and it is expected a
higher impact in individuals with poor metabolic control. The
inclusion of patients with good metabolic control may have
underestimated the impact of the intervention, so it could be
expected an even better result if we could stratify by the
baseline HbA1c levels. The subgroup analysis comparing
studies with an average HA1c lower or higher than 8.0% (64.0
mmol/mol) is limited, because it is not possible to effectively
separate individuals with better and worst metabolic control.
However, as it demonstrated a significantly higher impact on
HbA1c in the subgroup of studies with baseline HbA1c equal to
or higher than 8.0%, it provides an estimative of a higher
impact of the intervention in patients with worst metabolic
control.
Although there was evidence of publication bias, trim-and-fill
method revealed that publication bias did not interfere with the
interpretation of results, as the imputed effect size was similar
to the original effect, suggesting that the apparent publication
bias is insufficient to affect our results or interpretations in a
meaningful way.
It is important to note that the endpoint HbA1c has some
limitations. As a mean, it may show normal results in
individuals who alternate hypo and hyperglycemias [37].
Besides this, it is necessary that laboratories use HbA1C assay
methods certified by the National Glycohemoglobin
Standardization Program (NGSP) as traceable to the DCCT
(Diabetes Control and Complications Trial) reference [38,39].
Finally, some clinical situations can lead to a HbA1C falsely
high or falsely low, such as pregnancy, hemoglobinopathies,
disorders of erythrocyte turnover, renal failure [37,40].
Conclusions
In conclusion, this systematic review and meta-analysis has
shown that telemedicine strategies combined with the usual
care are associated with improved glycemic control in diabetic
patients. In this review, there was no clinical relevant impact on
LDL-c and blood pressure, and there was a tendency of BMI
reduction in diabetes patients who used telemedicine, but the
impact on these outcomes should be further explored in future
trials.
A logical next step for future trials would thus be to assess
whether the improved glycemic control observed with
telemedicine interventions will translate into improved clinical
outcomes. The optimal design of telemedicine systems is
uncertain, so future research should also focus on what type of
telemedicine intervention has the largest impact on diabetes
management, and how to adapt systems to the individual
patient needs and resources of specific health care systems.
The evaluation of the cost-effectiveness of the intervention
should also be addressed, which is relevant to decision makers
and impacts on the applicability of the evidence in clinical
practice.
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